home | nokad technology | products | about nokad | contact us  
     
 
NEWS AND PRESS
 


  • October 19th, 2009
    Amine Abina, President and Chief Executive Officer of Nokad, today announced that NOKAD has closed a second round of financing for 1.6 million euros from new venture capital shareholder, SHAM, and existing venture capital shareholders, CapDecisif Management and G1J Ile-de-France. The raised funds will help NOKAD to prepare its first clinical trial for the treatment of congenital thrombocytopenia, and continue the expansion of its in vivo target validation platform (see press release in french).

  • December 11th, 2008
    Amine Abina, President and Chief Executive Officer of Nokad, today announced that NOKAD has received a $1.3 million grant from the national research agency (ANR) BiotechS program to support its therapeutic vaccine projects. This grant acknowledge the quality of the programs conducted in partnership with INSERM U790 Unit.

  • May 23rd, 2008
    Amine Abina, President and Chief Executive Officer of Nokad, will be at the Bio international Convention in San Diego (16-20 of June. He will be pleased to meet you at the partnering meetings or outside the convention schedule. For more information and registration click here.

  • February 13th, 2008
    Amine Abina, President and Chief Executive Officer of Nokad, will present its technology and new results at the French American Biotech Symposium on April the 2nd 2008, La Jolla (CA). For more information and registration click here.

  • November 9th, 2007
    NOKAD opens a new position for a laboratory technician.

  • May 29th, 2007
    Les Echos, the most read daily business newspaper published "Nokad modify mice by vaccination" (in french). See Press Release.

  • April 11th, 2007
    Biotechinfo published "Functional knock-out in rat" (in french). See Press Release.

  • February 27th, 2007
    Amine Abina, President and Chief Executive Officer of Nokad, will present the first functional knock-out in rat species at Charles River laboratories Seminar in Evry on April 4th at 9:15 am. See Press Release.

  • November 27th, 2006
    Nokad will present its technology at Genopole :
    "Functionnal Knockout Generation in every mammal species using immunological strategy at Genopole Evry."

  • October 1st, 2006
    NOKAD opens three positions:
    • A senior Business developer with experience in selling life science new technologies
    • Two senior scientists with skills in immunology, animal models and structural biology.
    For details send email to contact@nokad-technology.com

  • June 8th, 2006
    Nokad will present its technology and new results at Cambridge MA on june 8th 2006.
    For more informations and registration click here.

  • April 10th, 2006
    Nokad opens its new branch office via Bioteam in Cambridge-MA (USA) in order to increase his business development in north America. You can contact Keren Dahan for more information.

  • April 9th-12th, 2006
    You can meet Nokad at the international convention of Bio Chicago
    Contact us for more information.

  • March 8th - 10th, 2006
    You can meet Nokad at BioSquare Geneva, Switzerland.
    Contact us for more information.

  • November 5th, 2005
    Nokad presented his results for the strategy of generation of KO-like
    models in mice at the International Mouse Genome Conference.

  • July 12th, 2005
    Nokad raises funds from Cap Decisif and Genopole®1er Jour.
    Read more : (download pdf).
 
   
  © All Right Reserved. ® NOKAD v1.0 2004-2008 - Last update : 16/05/2008